Bio Path Holdings Inc - Bio-Path Reports Tumor Reduction in Phase 1/1B BP1001-a Trial
Bio Path Holdings Inc - Bio-Path在第10/10億 BP1001-a試驗中報告腫瘤減少
Bio Path Holdings Inc - Bio-Path Reports Tumor Reduction in Phase 1/1B BP1001-a Trial
Bio Path Holdings Inc - Bio-Path在第10/10億 BP1001-a試驗中報告腫瘤減少
譯文內容由第三人軟體翻譯。